SBIR/STTR Research Award

Circulating Prostate Cancer Progenitor Cell Assay Development

Award identifier 964501cedfd20d2a2c7a31837caf24edc68635032e57ee5570bece55d64676c0Awarding agency Department of Defense · Army

Award amount

$747,553

Program and phase

STTR · Phase II

Award year

2011

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
ANDROBIOSYS, INC.
Proposal award date
2010-08-04
Contract end date
Not reported
UEI
Not reported
Solicitation number
2008.A
Topic code
A08-T041

Research abstract

The technical objectives of this Phase II project are to identify unique biomarkers and produce molecular, antibody and peptide reagents that are specific for human prostate cancer progenitor stem cells. We propose to utilize the information from the Phase I award and subsequent research to develop assay reagents that would be used to develop a blood-based assay specific for circulating prostate cancer stem cells. This assay should prove to be an informative prognostic tool for predicting aggressiveness and metastatic potential of prostate cancer.

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.